BioCentury
ARTICLE | Company News

Ascentia Biomedical, University of Washington deal

August 22, 2005 7:00 AM UTC

ASCE received an option from the university to license an undisclosed family of compounds. The option includes preclinical compounds for breast cancer, sepsis and arthritis. ...